New prostate cancer drug extends life in terminal cases

Thousands of men are set to benefit from a revolutionary, life-extending prostate cancer drug that has been approved for use in Britain.The Medicines and Healthcare products Regulatory Agency (MHRA) gave the green light yesterday to use Pluvicto on terminal cancer patients. A trial on 551 showed the

Read the full article here

Related Articles